Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlotta Becherini

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Cancer Treatment Reviews|June 19, 2023
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysisCarlotta Becherini, Luca Visani, Saverio Caini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 20, 2023
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)Orit Kaidar-Person, Icro Meattini, Liesbeth J Boersma, et al.
Critical Reviews in Oncology/Hematology|January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacyStefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.
Critical Reviews in Oncology/Hematology|January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicityStefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.
The Lancet. Oncology|December 15, 2024
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trialIcro Meattini, Maria Carmen De Santis, Luca Visani, et al.
The Lancet. Oncology|March 1, 2023
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortiumStephanie G C Kroeze, Matea Pavic, Karin Stellamans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2026
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort studyCarlotta Becherini, Eva Blondeaux, Virginia Delucchi, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Cancer Treatment Reviews|June 19, 2023
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysisCarlotta Becherini, Luca Visani, Saverio Caini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 20, 2023
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)Orit Kaidar-Person, Icro Meattini, Liesbeth J Boersma, et al.
Critical Reviews in Oncology/Hematology|January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacyStefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.
Critical Reviews in Oncology/Hematology|January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicityStefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.
The Lancet. Oncology|December 15, 2024
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trialIcro Meattini, Maria Carmen De Santis, Luca Visani, et al.
The Lancet. Oncology|March 1, 2023
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortiumStephanie G C Kroeze, Matea Pavic, Karin Stellamans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2026
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort studyCarlotta Becherini, Eva Blondeaux, Virginia Delucchi, et al.
Pageof 8